The intravenous (IV) equipment market in South Africa has grown strongly, owing mostly to an increase in the frequency of chronic diseases requiring continuous medical interventions as well as developments in healthcare infrastructure across the country. IV catheters, infusion pumps, administration sets, and accessories are among the products available in the IV equipment market. The increased demand for effective and precise drug delivery systems is a major driver driving the market's rise. South African healthcare providers are increasingly using modern IV technology to ensure exact dosage delivery and reduce the possibility of pharmaceutical errors. With a focus on improving patient outcomes and minimising healthcare-associated infections, there is a rising preference for technologically advanced and safer IV equipment. The market for IV catheters, which are critical in obtaining vascular access for infusion therapy, has grown significantly. In order to reduce the occurrence of needlestick injuries and infections, manufacturers are working on producing catheters with better safety features. Furthermore, the rising prevalence of chronic disorders such as diabetes, cancer, and cardiovascular disease has increased demand for infusion therapy, pushing IV catheter sales. Government initiatives targeted at strengthening healthcare infrastructure and providing access to excellent medical services, particularly in rural areas, are expected to drive IV equipment demand in South Africa even further. Medical devices are subject to a rigorous regulatory process in South Africa. SAHPRA's Medical Devices Unit oversees the licencing of medical device companies as well as the registration of medical devices. South Africa also has a company that specialises in the manufacture and delivery of IV treatment medical devices. VIVAline™ is a licenced SAHPRA medical manufacturer and supplier. South Africa has seen a rise in demand for IV drips since their launch in 2015. Vitamin IV drips provide clients with vitamins for wellness instead of essential nutrients in a hospital environment. According to the research report "South Africa Intravenous (IV) Equipments Market Research Reports," published by Actual Research, the South Africa Intravenous (IV) Equipments market is projected to add more than USD 15 Million from 2023 to 2028. South Africa's healthcare industry has several unique aspects related to the intravenous (IV) equipment market. The country's concerted attempts to alleviate healthcare inequities among its varied population are one key component. While South Africa has a growing healthcare infrastructure, it has issues such as accessibility, especially in rural and neglected areas. The IV equipment market reflects this contrast, with urban areas seeing higher adoption rates of modern IV technology than rural areas, where accessibility remains an issue. Another noteworthy aspect is the increased emphasis on public-private partnerships and attempts to improve healthcare. The South African government works with commercial organisations to improve healthcare facilities and encourage the use of modern IV technology, with the goal of closing gaps in healthcare access and improving patient outcomes. This collaborative approach affects market dynamics by stimulating innovation and the launch of cost-effective yet technologically superior IV solutions to serve a broader demographic. The demographic and epidemiological landscape also has an impact on the IV equipment industry. South Africa faces a high illness burden, including HIV/AIDS, TB, and non-communicable diseases (NCDs) such as diabetes and cardiovascular disease. This health profile has an impact on the need for IV equipment, particularly infusion pumps and catheters, which are essential in administering medicines for chronic illnesses that require long-term maintenance.
Asia-Pacific dominates the market and is the largest and fastest-growing market in the animal growth promoters industry globally
Download SampleBased on product market is segmented into IV catheters, infusion pumps, administration sets, securement devices, needless connectors, stopcocks and check valves, drip chambers and others. Among them IV catheters product is predicted to lead the market of South Africa IV equipments market. IV catheters are essential for establishing vascular access and allowing drugs, fluids, or blood products to be administered directly into the bloodstream. They play an important role in a variety of medical procedures, from everyday treatments to emergency care. Chronic diseases such as diabetes, cardiovascular disease, and HIV/AIDS pose a huge burden in South Africa. Managing these illnesses frequently demands long-term or repeated intravenous therapy, resulting in a steady demand for IV catheters. The need for IV catheters is increasing as healthcare facilities across South Africa expand and improve. Catheters are required by hospitals, clinics, and specialised care centres to provide intravenous therapies to patients. In order to decrease the possibility of infection and needlestick injuries, disposable and safety-engineered IV catheters are becoming more popular, harmonising with worldwide healthcare standards. This move increases demand for innovative, safer catheter choices, boosting market growth. Government measures to improve healthcare infrastructure and quality of care, particularly in underserved areas, encourage the usage of medical devices such as IV catheters. Efforts to improve healthcare accessibility across the country contribute to the consistent demand for these critical products. In terms of end users market is segmented into hospitals, clinics, home care settings and others. Home care settings end user segment is expected to grow at rapid pace in South Africa intravenous equipments market. Advances in technology have resulted in the creation of portable and user-friendly IV equipment ideal for home use. This comprises tiny infusion pumps, wearable devices, and user-centric IV administration sets, allowing healthcare practitioners to successfully deliver medications in home care settings. Government measures supporting home-based care and community health services help to drive this segment's growth. Home healthcare services, including intravenous treatments, are included in policies aimed at decongesting hospitals and boosting healthcare access for remote or underserved areas. Patients are increasingly seeking active participation in their healthcare decisions. Patients are empowered in home care settings because they can control their treatment schedules and are actively involved in their care plans, which frequently include IV therapies for a variety of diseases. Telemedicine and remote monitoring technology have advanced, allowing healthcare providers to remotely monitor patients getting IV treatments at home. These advancements improve patient safety and enable prompt interventions, bolstering the sustainability of home-based IV therapy. Improvements in logistics and supply chain management make it possible to deliver IV equipment and medications to home care settings. Improved infrastructure supports the provision of intravenous therapies outside of typical healthcare institutions by ensuring timely and efficient delivery of critical supplies. Considered in this report: • Geography: South Africa • Historic year: 2017 • Base year: 2022 • Estimated year: 2023 • Forecast year: 2028
Aspects covered in this report: • South Africa Intravenous (IV) Equipments market with its value and forecast along with its segments • Various drivers and challenges • On-going trends and developments • Top profiled companies • Strategic recommendation By Product: • IV Catheters • Infusion Pumps • Administration Sets • Securement Devices • Needless Connectors • Stopcocks and Check Valves • Drip Chambers • Others By End User: • Hospital • Clinics • Home Care Settings • Others
By Indication: • Cardiovascular Disorders & Hypertension • Pregnancy • Diabetes • Respiratory Diseases • Cancer • Movement Disorders • Wound Care • Other Indications (sleep disorders, kidney disorders, neurovascular diseases, and HIV) The approach of the report: This report consists of a combined approach of primary as well as secondary research. Initially, secondary research was used to get an understanding of the market and list out the companies that are present in the market. The secondary research consists of third-party sources such as press releases, and annual reports of companies, analyzing the government-generated reports and databases. After gathering the data from secondary sources primary research was conducted by making telephonic interviews with the leading players about how the market is functioning and then conducting trade calls with dealers and distributors of the market. Post this we have started doing primary calls to consumers by equally segmenting consumers into regional aspects, tier aspects, age groups, and gender. Once we have primary data with us we started verifying the details obtained from secondary sources. Intended audience: This report can be useful to industry consultants, manufacturers, suppliers, associations & organizations related to the Intravenous (IV) Equipments industry, government bodies, and other stakeholders to align their market-centric strategies. In addition to marketing & presentations, it will also increase competitive knowledge about the industry.
We are friendly and approachable, give us a call.